|
315 Pharmacy set for
further involvement in primary care Pharmacies
could be involved in the provision of a much wider range of primary care
services in future, Secretary of State for Health Alan Johnson indicated
at a press briefing this week. He said that the Government is aware that
it has to do more to ensure that everyone is guaranteed the same high
standard of care no matter where they live
PJ 2007;279:315
Full Text
315 CBI points out faults in PCT commissioning Primary
care trusts in England have been criticised by the CBI for failing to
use fully their new powers to commission innovative services from pharmacies.
The CBI sees such new services as one way of reducing the UK's annual
loss of 3.5 million working days due to ill health
PJ 2007;279:315
Full Text
315 People’s view of NHS sought A public consultation on the future of the NHS started this week with nine events held across Britain involving over 1,000 members of the public, patients and clinicians. “Our NHS, our future” is being led by health minister Lord Darzi and is seeking to find out the public’s views on how health care can be improved and priorities for action
PJ 2007;279:315
Full Text
315 National minor ailment scheme ambitions
given boost by Secretary of State for Health Proposals
for a national minor ailments scheme have resurfaced following comments made
last week by Alan Johnson in his first major speech as Secretary of State for
Health. The Pharmaceutical Services Negotiating Committee has written to the
health secretary requesting a meeting to discuss the proposals and the Royal
Pharmaceutical Society has also responded
PJ 2007;279:315
Full Text
316 International suppliers
of fake drugs convicted Ashish Halai, of Elstree,
Hertfordshire, has been jailed for four and a half years after being convicted
of conspiracy to deal in counterfeit medicines. Mr Halai was found guilty this
week at Kingston Crown Court on 11 charges under the Medicines Act 1968 and the
Trade Marks Act 1994
PJ 2007;279:316
Full Text
316 Complaints up after new ABPI code launched Complaints
to the Prescription Medicines Code of Practice Authority about the promotion
of medicines rose substantially in the year after the code was revised and promoted
heavily to potential complainants. The new code came into effect in January 2006
PJ 2007;279:316
Full Text
316 Deals between wholesalers are weak link
in supply chain Grey trade is probably the most
overlooked route for counterfeit drugs to enter the supply chain, according to
Paul Forster-Jones, managing director of Cordia Healthcare, one of Alliance Boots's
short-line wholesaling businesses
PJ 2007;279:316
Full Text
316 Pfizer calls time at Sandwich Pfizer
is to close its manufacturing facility in Sandwich, Kent, with the loss of 420
jobs over the next two years
PJ 2007;279:316
Full Text
316 UniChem does deal with Sangers Sangers
(NI) will supply medicines on UniChem's behalf in Northern Ireland under a new
agreement
PJ 2007;279:316
Full Text
316 Rebif goes zero-discount Rebif (interferon beta-1a) 8.8µ/0.2ml solution for injection pre-filled syringes have been added to the Drug Tariff list of drugs for which discount is not deducted
PJ 2007;279:316
Full Text
317 Practice-based commissioning
awareness week Pharmacy practice-based commissioning
(PBC) week kicks off on Monday with several activities organised both nationally
and locally
PJ 2007;279:317
Full Text
317 Guide highlights support NHS pharmacists
can offer to commissioners What primary care pharmacists
can do to support practice-based commissioners has been encapsulated in a guide
launched by the Primary Care Pharmacists' Association and the NHS Alliance this
week
PJ 2007;279:317
Full Text
317 SOP report stresses benefits of closer pharmacist/GP
working Closer working between community pharmacists
and GPs is key to achieving faster access to better services in primary care,
according to a report published this week by the School of Pharmacy, University
of London, in partnership with Alliance Boots
PJ 2007;279:317
Full Text
318 Zoledronic acid once yearly
after hip fracture improves survival rate Once yearly infusions of zoledronic acid — started within the three months following repair of a hip fracture — improves survival and reduces the rate of new clinical fractures, a randomised controlled trial shows
PJ 2007;279:318
Full Text
318 Deaths among critically ill cut by epoetin
alfa Treatment with epoetin alfa reduces mortality
in critically ill patients, a new study has shown
PJ 2007;279:318
Full Text
318 Novel anticonvulsant for Lennox-Gastaut
patients A novel anticonvulsant medicine will be
launched in the UK next week for patietns with Lennox-Gastaut syndrome —
a severe and difficult-to-treat form of epilepsy that begins in childhood. Available
from Eisai, rufinamide (Inovelon) was granted orphan drug status by the European
Commission in 2004 for treatment of the syndrome
PJ 2007;279:318
Full Text
318 Safety of glitazones Further
evidence linking glitazones with an increased risk of heart failure has been
published
PJ 2007;279:318
Full Text
318 Carvedilol for children Children
and adolescents with heart failure do not appear to benefit from treatment with
carvedilol
PJ 2007;279:318
Full Text
318 Childhood vaccination Health
minister Ben Bradshaw has confirmed that the Joint Committee on Vaccination and
Immunisation has commissioned an expert subgroup to consider the benefits of
vaccinating children against chickenpox and of vaccinating adults against shingles
PJ 2007;279:318
Full Text
319 Pharmacists should check
medicines on admission Pharmacists should be involved
in medicines reconciliation as soon as possible after patients are admitted to
hospital, according to draft safety guidance produced by the National Institute
for Health and Clinical Excellence in collaboration with the National Patient
Safety Agency
PJ 2007;279:319
Full Text
319 NHS what-not-to-wear guidance aims to cut
infection rate in hospitals Guidance to help NHS
trusts develop local policies on appropriate workwear has been published this
week by the Department of Health in a further bid to address health care-associated
infections (HCAIs)
PJ 2007;279:319
Full Text
319 Institute of Life Science to stimulate health
research in Wales Multidisciplinary health care
research has been given a boost with the opening of a centre in Swansea. As well
as having the latest research and laboratory facilities, Swansea University's
Institute of Life Science also hosts a business development centre, which aims
to build long-term commercial and academic links and enhance employment opportunities
in the region
PJ 2007;279:319
Full Text
319 Moorfields launches colour-coded packaging
for eye-drops Moorfields Pharmaceuticals has launched
a colour-coded packaging system for its ophthalmic specials range
PJ 2007;279:319
Full Text
320 MPs criticise clarity
of plans for NHS care records The NHS Care Records
Service, a central part of the National Programme for IT in England, has been
criticised by MPs in the Health Committee's latest report, published last week
PJ 2007;279:320
Full Text
320 Discrimination fears with tighter regulation Government
plans to tighten the regulation of health professionals could lead to discrimination
against disabled people and those with long-term conditions, the Disability Rights
Commission has warned in a new report
PJ 2007;279:320
Full Text
320 Consultation starts on list of diseases
for which new drugs will not need paediatric tests Consultation
has started on a draft list of diseases for which new drugs will automatically
be exempt from recently introduced European requirements to test their suitability
for use in children
PJ 2007;279:320
Full Text
320 Repeat dispensing offers business opportunity Two
community pharmacies in Worthing, West Sussex, have formed a company with GPs
in the town to offer online ordering of repeat prescriptions by patients
PJ 2007;279:320
Full Text
320 Paucity of clinical governance in primary
care Clinical governance is not as well established
in primary care as it is in secondary care, a report by the Parliamentary Public
Accounts Committee concludes
PJ 2007;279:320
Full Text |
The
Pharmaceutical Journal